New compound name drops — heard about X?

SLU-PP-332 is a real ERR agonist with real animal data. Zero human data. Being marketed like there's human data. Tread carefully.

Most 'new' compounds are either (a) repurposed research chemicals with 2 papers, (b) isomers of existing peptides, or (c) marketing.

Reta is the only 'new' one I'd say is genuinely worth paying attention to right now and the trial data is actually solid. Everything else is secondary.

Humanin analogs have been 'about to break out' for 5 years and still haven't. I've stopped buying the hype cycle.

If the compound name sounds cool (3-4 letters and a number), that's the first red flag it's being marketed to you.

CagriSema is legit and the data is out there if you look. But it's a GLP-1/amylin combo not a 'new class' exactly.